{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-22-024955","form_type":"8-K","ticker":"LMAT","cik":"0001158895","company_name":"LEMAITRE VASCULAR INC","filed_at":"2022-10-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:49.767632+00:00","generated_at":"2026-06-22T23:38:33.302111+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"LeMaitre Q3 sales $39M (+2%), EPS $0.25 (-17%); declares $0.125 dividend","bullets":["Q3 sales $39.0M (+2% reported, +7% organic YoY); EPS $0.25 diluted, down 17%.","Q3 operating income $6.2M, -32%; net income $5.5M, -16%.","Full-year 2022 guidance: sales $160.5M-$162.9M; EPS $0.91-$0.97 (ex-special $1.02-$1.08).","Quarterly dividend of $0.125/share, payable Dec 1, 2022 to holders of record Nov 17.","Appointed Martha Shadan as independent director, effective Sept 21, 2022."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-22-024955","json":"https://secwatch.observer/filing/0001437749-22-024955.json","markdown":"https://secwatch.observer/filing/0001437749-22-024955.md","text":"https://secwatch.observer/filing/0001437749-22-024955.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1158895/000143774922024955/0001437749-22-024955-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1158895/000143774922024955/lmat20221027_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-22T23:38:33.302111+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}